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Amyotrophic lateral sclerosis (ALS) is a devastating, rapidly progressing disease of the central nervous
system that is characterized by motor neuron degeneration in the brain stem and the spinal cord. We
employed time of flight secondary ion mass spectrometry (ToF-SIMS) to profile spatial lipid- and
metabolite- regulations in post mortem human spinal cord tissue fromALS patients to investigate chemical
markers of ALS pathogenesis. ToF-SIMS scans and multivariate analysis of image and spectral data were
performed on thoracic human spinal cord sections. Multivariate statistics of the image data allowed
delineation of anatomical regions of interest based on their chemical identity. Spectral data extracted from
these regions were compared using two different approaches for multivariate statistics, for investigating
ALS related lipid and metabolite changes. The results show a significant decrease for cholesterol,
triglycerides, and vitamin E in the ventral horn ofALS samples, which is presumably a consequence ofmotor
neuron degeneration. Conversely, the biogenic mediator lipid lysophosphatidylcholine and its fragments
were increased in ALS ventral spinal cord, pointing towards neuroinflammatory mechanisms associated
with neuronal cell death. ToF-SIMS imaging is a promising approach for chemical histology and pathology
for investigating the subcellular mechanisms underlyingmotor neuron degeneration in amyotrophic lateral
sclerosis.
A
myotrophic Lateral Sclerosis (ALS) is a very progressive, fatal disease that is characterized by irreversible
degeneration of motor neurons in the spinal cord, brain stem, and cortex resulting in increasing muscle
weakness andmuscle atrophy1. ALS has a prevalence of 2–4 cases per 100 000 a year with a common onset
age between age 40 and 60 and an average life expectancy three to five years after diagnosis2. Most ALS cases are
idiopathic in nature; however, 10% have been found to be caused by genetic factors2. The main mechanisms
underlying ALS are still unknown, although a couple of findings concerning molecular ALS pathology have been
reported mainly focusing on genetic causes3–5. The limited knowledge of the disease results in further drawbacks
such as the inaccuracy and time delay for diagnosis, which highlights the need for further investigation of the
disease on a molecular level.
The limited understanding of molecular ALS pathobiology relates directly to the lack of appropriate analytical
technologies that feature the necessary sensitivity and specificity. Studying complex biological and pathological
processes requires acquisition ofmolecular images, since these processes involve the translocation and interaction
of a wide range of chemical species.
Mass spectrometry based molecular imaging (IMS) is an emerging technique for probing the molecular
architecture of biological tissue in an anatomical context6. In contrast to common molecular biology techniques,
IMS does not require any a priori knowledge of the potential target species and allows direct and comprehensive
identification and spatial profiling of biomolecular species in situ, while maintaining high molecular specifi-
city7–10. A major advantage of ToF-SIMS based imaging MS is the possibility to robustly acquire high-resolution
images at the cellular length scales (1–5 mm), without compromising sample treatment procedures11–13. These
features make SIMS a powerful technology for spatially profiling lipids and metabolites at the single cell level14.
This is of particular relevance for studying complex and heterogeneous samples, such as neuronal tissue and cells,
which arguably constitute the most complex and least understood systems in the human body7,15. ToF-SIMS
based molecular imaging represents therefore a promising approach for investigating spinal cord biochemistry.
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Several studies on spinal cord using various imaging mass spec-
trometry techniques have been reported that have provided import-
ant data on spinal cord pathology16–22. In a recent study, we probed
the native distribution of lipids andmetabolites in human spinal cord
using ToF-SIMS for high spatial resolution imaging23. In addition,
different strategies for multivariate analysis of whole image datasets
for tissue segmentation were evaluated that in turn facilitate iden-
tification of anatomical regions of interest based on their chemical
identity.
Here we report the use of ToF-IMS based analysis of post mortem
human spinal cord tissue samples in conjunction with multivariate
data analysis (MVA) to identify ALS related changes in spinal cord
lipid chemistry and metabolism in situ. This work should gain fur-
ther insight in molecular mechanisms underlying ALS, particularly
with respect to lower motor neuron degeneration.
Results
Multivariate image analysis for identification of anatomical re-
gions of interest in human spinal cord. For each individual (n5 5; 2
control/3 ALS), subsets of two consecutive tissue sections were
analyzed with ToF-SIMS in both positive and negative ion mode.
The datasets were calibrated internally and reconstructed with a
common mass interval list (binning) for data acquired in both
positive- and negative ion mode. This resulted in a total of 20
imaging datasets (10 pos.- and 10 neg. mode), each at least 3 GB
in size. Imaging data from the 20 datasets were subjected to
unsupervised multivariate statistical image analysis by means of
maximum autocorrelation factor analysis (MAF)24,25. This resulted
in generation of eigenvalue (score) images that depict the chemical
variance captured in the respective factors of the MAF analysis
(Figure 1). This image analysis approach revealed characteristic
outlines of the grey and white matter (Figure 1). The molecular
species that outline the histological regions and cellular environ-
ments can then be deduced from the loadings (eigenvectors) and
provide further information on local lipid biochemistry and
metabolism.
Multivariate analysis of region of interest data allows discrimina-
tion of ALS and control groups. Two different multivariate
approaches, partial least square discriminant analysis (PLS-DA)
and ‘‘Statistical Analysis of Microarray Data’’ (SAM), were
employed for statistical analysis of spectral data extracted from
anatomical regions of interest (ROI). These histological regions
including the whole grey matter (GM) as well as the ventral horn
of the grey matter (VH) were assigned in accordance with the image
analysis data (Figure 2A). The ROI data of the GM and the VH of
each patient were normalized to the total ion count (TIC), log2
converted, and different ionization modes were pooled for each
patient. This gave two sample/variable matrices for both the GM
ROI and the VH ROI that were then evaluated by means of
multivariate analysis using two different strategies. Here, as a first
approach for MVA, multivariate analysis by means of PLS-DA was
performed. PLS-DA is a linear regression extension of principal
component analysis (PCA) and well suited for comparing two
different sample groups. PLS-DA was performed after mean center-
ing and Poisson scaling and resulted in distinct discrimination of the
two groups (Control and ALS) both for the grey matter region and
Figure 1 | Image Data Analysis for Tissue Segmentation. Multivariate statistical analysis of imaging MS data by means of maximum autocorrelation
factor analysis (MAF) reveals anatomical regions of human spinal cord including grey and white matter in both control and ALS samples. Composition
images of corresponding factors (i.e. components, MA-factors) allow identification of anatomical regions of interest. Each pixel intensity represents the
respective score (eigenvalue, see scale). Scale bar 5 4 mm.
Figure 2 | Multivariate statistics of ROI spectral data using PLS DA.MS spectral data from previously outlined anatomical regions (A), including the
grey matter (GM) (B) and ventral horn (VH) (C), were subjected tomultivariate analysis using PLS DA. (B,C) PLS DA score plots demonstrate grouping
of ALS samples (green) and controls (red).
www.nature.com/scientificreports
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even more pronounced for the ventral horn data (Figure 2B, C).
From the corresponding loading plots the individual variables (m/z
values) were deduced that have the greatest impact on the score and
thereby separation (SI Figure 1A, B).
As a second approach, the ‘‘Statistical Analysis of Microarray data’’
tool26 was used for grouped unpaired t-statistics of the ALS and con-
trol group data for each ROI (GM and VH) (Figure 3A). For the whole
grey matter region the results show significant intensity changes (p,
0.05) for in total 21 m/z values. Here, four mass peaks were signifi-
cantly increased in ALS (red), while a number of 17 species were
higher in the control group (green, Figure 3B). For the ventral horn
region; however, the data show significant changes (p , 0.05) for
175 m/z values that were found either increased (130) or decreased
(45) in the ALS samples compared to the controls (Figure 3C).
For verification of these findings, SAM results for the respective
ROI were compared to the results obtained from PLS-DA. Here, the
PLS-DA derived variables (loadings) that exhibited the greatest con-
tribution to the corresponding score of the individual samples were
investigated. Only, m/z compounds that were found significant in
SAM and displayed a large PLS-DA loading value were considered.
For the grey matter region all 21 compounds that were found sig-
nificantly changed in between ALS and controls were also found to
have a large loading value in PLS-DA. In contrast, of the 175 signifi-
cant observed in SAM analysis for the VH region, only 40 were found
to have a large loading value. These were then further verified using
non-parametric unpaired statistics (Kruskal-Wallis). This resulted in
a number of 38 compounds that were found significantly changes in
the ventral horn in between ALS and control samples. A number of
15 peaks were increased and 23 peaks were decreased in ALS ventral
horn as compared to controls. Here, for the decreased compounds all
peaks were detected in negative mode, while for increased com-
pounds 7 were detected in positive and 8 in negative mode.
Regional changes of spinal cord lipids associated with ALS. The
most prominent signals were tentatively assigned based on accurate
mass matching and comparison to values reported in the litera-
ture27–29 as well as by matching the experimental data to predicted
isotopic patterns. Multivariate analysis of the ROI spectral data
resulted in 6 molecular species that were found decreased in the
grey matter as well as in the ventral horn of ALS spinal cord.
Five of these peaks could be assigned to triglyceride species (TG,
Figure 4A)28,29, while one compound (m/z 446.3) could not be
identified. Further mass peak results obtained for the whole GM
ROI could not be verified by manual inspection of the single ion
images. By confining comparative analysis to the VH region more
species were found significantly changed in between ALS and
controls. Among the most prominent compounds that displayed an
ALS associated decrease, cholesterol (C27H45O: [M2H]2 385.3) and
vitamin E (C29H49O2: [M 2 H]2 429.3) could be identified27. For
both species a significant decrease was observed in the ventral horn
region of controls as compared to ALS samples (Figure 4B).
Conversely, a number of compounds were found increased in the
ventral horn of ALS tissue as compared to controls. This included
phosphatidylcholine (PC) -lipid fragments (TME, trimethylethyli-
mine: m/z 86.1, [C5H12N1]; PC-headgroup: m/z 184.1 [C5H15
PO4N1]) as well as intact lysophosphatidylcholine (LPC (1650),
m/z 496.5 [M 1 H]1) (Figure 5A). Furthermore, protein associated
signals (m/z 26.01, [CN2]; m/z 80.96 [NaKCN1]) and hydrogensul-
fite [HSO32] were found elevated in the ventral horn of ALS spinal
cord samples (Figure 5B).
Discussion
The spinal cord constitutes the interface of the peripheral and the
central nervous system comprising essential circuits inmotor control
as well as somatosensory function. Anatomically, the tissue is gen-
erally separated into the white matter and grey matter. Nervous
tissue is characterized by its high complexity and diversity. This will
eventually be reflected in the spatial intensity distribution pattern of
biochemical species and in turn affect signal intensity values based on
changes in the biochemical background. Therefore comparison
between heterogeneous tissue specimens requires identification
and annotation of distinct anatomical regions so that histological-
and biochemical similar areas can be compared in between different
individuals. For comparative analysis, we employed a ToF-SIMS
imaging data guided approach for tissue segmentation of spinal cord
samples. The aim was to outline anatomical regions of interest based
on their chemical identity. This approach was based on multivariate
analysis of whole scan image data using maximum autocorrelation
factor analysis. The suitability of this approach was evaluated in a
recent study by our group, where we compared the performance of
PCA and MAF for image analysis with respect to contrast and their
ability to identify anatomically relevant regions of interest23. Here, a
MAF based image analysis guided strategy for ROI assignment was
found to be a robust and straightforward approach for tissue seg-
Figure 3 | Statistical Analysis of Spectral Data using SAM. Spectral data of previously outlined regions as revealed by image analysis were subjected to
statistical analysis of microarray data (SAM). Spectra acquired in positive and negative mode for the GM- and VH-areas (A) were analyzed. (B, C) SAM
plots illustrate relative changes of ALS versus control in the respective areas as revealed by unpaired t-statistics. The x-axis illustrates the degree of
significance, while the y-axis refers to the observed degree of change. Red illustrates a relative increase in ALS compared to control, while green illustrates a
relative decrease in ALS to control. The borders indicate the significance threshold (p , 0.05).
www.nature.com/scientificreports
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mentation23. MAF employs an implemented correction to the noise
covariance matrix as achieved by an iterative comparison to adjacent
pixel spectra. In contrast to PCA, this approach is therefore not
dependent on data preprocessing (e.g. scaling, mean centering)
and thus provides better contrast and sensitivity that allow catching
slight intra tissue heterogeneities, although the technique is compu-
tational demanding. This highlights an important consideration for
bulk-image data analysis with respect to sample size and data hand-
ling. Given the large data file size obtained from the SIMS and other
IMS experiments (up to 10 GB), tradeoffs with respect to pixel reso-
lution and number of peak assignments (bins) have to be made.
Given the fact that most commercial solutions for image data ana-
lysis, as provided by the manufacturers, are still limited to 32-bit
systems, the complexity of downstream data analysis approaches
have to be considered in advance. In the present study, MAF facili-
tated exact annotation of these regions and was employed for sub-
sequent extraction of ROI spectral data for comparative analysis of
the localized chemistry in ALS tissue compared to controls. Using
PLS-DA as well as SAM based statistics, the most significant changes
were observed by confined comparative analysis of the ventral horn
region (Figure 2 and 3). These observations further demonstrate that
targeted ROI data analysis is mandatory to reveal local, disease
related, biochemical changes. Indeed, ALS is characterized by degen-
eration of spinal cord motor neurons in the ventral horn. Spatially
confined changes in lipid and metabolite expression are easily con-
voluted, if the ROI is assigned toowidely, which further illustrates the
relevance for targeted imaging data analysis when analyzing hetero-
geneous biological tissue.
A decrease of triglyceride species was observed throughout the
whole grey matter (Figure 4A). This is consistent with previously
reported results showing an ALS associated increase in clearance of
peripheral lipids, including triglycerides30. In that work, an altered
energymetabolism was observed in experimental ALS (mSOD1mice)
that resulted in increased TG metabolism. This shift in energy meta-
bolism relates to an increased demand of nutrients in muscle tissue as
a consequence of dysfunctional skeletal muscle metabolism30.
While 21 m/z peaks were found statistically changed between ALS
and control spinal cords for the whole GM region, they could not be
Figure 4 | Single Ion Images of Chemical Species decreased in ALS. Multivariate statistics of ROI spectral data using SAM and PLS DA resulted in
detection of multiple molecular species displaying ALS associated decrease in the grey matter. Only compounds observed in negative mode displayed a
decrease in ALS spinal cord. (A)Here, a decrease throughout the whole greymatter (arrows) was observed for various triglycerides (TG (4654), [M2H]2
769.6; TG (4653), [M2 H]2 771.6; TG (5051), [M2 H]2 831.7). (B) Similarly, an unidentified peak atm/z 446.3 was found decreased in both ventral
horn and whole grey matter (arrows). In contrast, cholesterol (C27H45O, [M 2 H]
2 385.3) and vitamin E (C29H49O2, [M 2 H]
2 429.3) were found
consistently decreased in the ventral horn of ALS spinal cord but not in the whole grey matter. Scale bar 5 4 mm.
www.nature.com/scientificreports
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verified by manual inspection of the single ion images. This in turn
highlights the importance of strict validation of MVA results by
subsequent inspection of the imaging raw data. As mentioned prev-
iously, further refinement of the GM-ROI to the ventral horn yielded
a significantly higher number of ALS associated molecular species
(Figure 3C). Here, the data show that cholesterol (C27H45O: [M 2
H]2 385.3) and vitamin E (C29H49O2: [M 2 H]2 429.3) were
increased in the ventral horn region of controls as compared to
ALS samples (Figure 4B). Cholesterol and vitamin E are major con-
stituents of the myelin sheath surrounding ascending and descend-
ing axons that constitute the white matter but also innervate the grey
matter regions. These results are consistent with the fact that ALS
is characterized by neuronal degeneration in the ventral horn.
Decreased levels of the myelin sheath constituents correspond to
decreased innervation as a result of neuronal cell death. Moreover,
the degree of decreased white matter compounds may serve as a
neuropathological hallmark of neurodegenerative mechanisms
underlying ALS.
An ALS associated increase of lipids and metabolites was also
observed and verified in the ventral horn (Figure 5). Here,
SAM and PLS-DA revealed an increase in PC-lipid fragments
(PC-headgroup and TME, Figure 5A) in the ventral horn of the grey
matter in ALS patients (Figure 5A). Similarly, LPC (1650) was sig-
nificantly increased in the same region in ALS spinal cord tissue,
while no other phospholipids displayed any significant change
(Figure 5A). PC-headgroup and TME are most likely fragments of
LPC resulting from in-source fragmentation. The signal can however
also originate from sphingomyelin31. A mass peak at m/z 224.1 cor-
responding to the PC-lipid specific fragment C8H19PNO41 (PC-
headgroup1 C3H4) displayed similar distribution pattern and regu-
lation in intensity as the other PC fragments (SI Figure 2)31. This
verifies that the PC attributed mass peaks (m/z 184.1; m/z 86.1) do
indeed originate from PC-lipids, rather than sphingomyelin.
LPC is a precursor for lysophosphatitic acid (LPA), a biogenic
lipid. This lipid mediator is synthesized from LPC by autotaxin
(ATX) that was demonstrated to possess lysophospholipase D activ-
ity32. Interestingly, in cerebrospinal fluid (CSF) the levels of LPC and
LPA are very low despite significant amounts of ATX, which indi-
cates that LPC production would be a rate-limiting step for LPA
production33. LPA production and activity in the spinal cord has
been described before, where LPA was found to exert its activity
through LPA1-receptor signaling, which initiates neuropathic pain
Figure 5 | Single Ion Images of Chemical Species elevated in ALS spinal cord. Multivariate statistics of ROI spectral data using SAM and PLS DA
resulted in detection of several molecular species displaying ALS associated increase in the greymatter. (A) These included lysophosphatidylcholine (LPC
(1650), [M1H]1 496.5, arrow) as well as its fragments, PC-headgroup (PC) and trimethylethylimine (TME), observed in pos. ionmode. (B) In addition,
protein fragments (m/z 26.01, [CN2] andm/z 87.9, [NaKCN1]) as well as hydrogensulfite (m/z 80.96, [HSO3
2]) were found elevated in the ventral horn
of ALS spinal cord (arrow). Scale bar 5 4 mm.
www.nature.com/scientificreports
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and underlying mechanisms including demyelination34. Elevated
LPA levels are a consequence of serum leakage through tissue
damage but also result from abnormally elevated LPA biosynthesis35.
LPA/LPA1-receptor signaling in the spinal cord was found to initiate
e.g. neuropathic pain through different demyelination pathways35.
These include phosphoinositol-bi/tri-phosphate (PIP2/PIP3) second
messenger mediated genomic regulation of myelin protein express-
ion36 as well as inositoltriphosphate (IP3) mediated myelin degrada-
tion by calpaein37. This is consistent with the observations presented
here, where decreased cholesterol and vitamin E values indicate
demyelination. In addition to these observations, a significant
increase of protein specific fragments (m/z 26.01, [CN2]) was
observed in the ventral of the ALS spinal cord (Figure 5B). Similar
to other neurodegenerative diseases, ALS is characterized by pro-
gressive accumulation and aggregation of misfolded proteins into
insoluble protein aggregates. Increased protein signals therefore
indicate impaired protein turnover. Again, this is consistent with
previously reported observations, where a diminished proteasome
activity has been observed in the ventral horn of ALS patients38,39.We
also observed increased levels of hydrogen sulfite (m/z 80.9,
[HSO32]) in the ventral horn of ALS spinal cord. Sulfite is a meta-
bolite of cysteine, which accumulates when one or more of the
enzymes needed for glutathione (GSH) synthesis are defective40.
Sulfite exerts its neurotoxic potential through direct inhibition of
glutamate dehydrogenase thereby impacting ATP biosynthesis40.
The present observations on spinal cord sulfite accumulation indi-
cate cysteine and sulfite mediated neurotoxicity as a consequence of
disrupted GSH metabolism, as has been discussed earlier41.
Conclusions
The potential of ToF-SIMS imaging for interrogating the biochem-
ical architecture of the human spinal cord in ALS is demonstrated.
Multivariate statistics used for image data guided tissue segmenta-
tion facilitate accurate outlining of histological regions of interest
based on their chemical identity. Spectral data analysis of these
ROI’s revealed spatially confined changes in lipid and metabolite
regulation associated with ALS pathogenesis. ALS implicated
decrease of cholesterol and vitamin E in the ventral horn was
observed presumably associated with demyelination andmotor neu-
ron degeneration. In addition, ventral horn triglyceride clearance
indicates ALS related changes in energy metabolism, while an accu-
mulation of hydrogen sulfite and LPC in the ventral horn point to
metabolic neurotoxicity and biogenic lipid induced neuroinflamma-
tion, respectively. The data presented reveal novel targets for investi-
gating ALS pathology in spinal cord that have not been presented
before. ToF-SIMS can be used to reveal disturbances in the neuro-
chemical interplay affecting neuronal functionality and integrity and
suggests a novel approach for future investigations concerningmotor
neuron degeneration.
Methods
Chemicals and Reagents. All chemicals were of pro-analysis grade and purchased
from Sigma Aldrich (St. Louis, USA). TissueTek optimial cutting tool (OCT) was
purchased from Sakura Finetek (AJ Alphen aan den Rijn,The Netherlands). Water
was purified with a Milli-Q (Millipore, Bedford, MA, USA) purification system.
Clinical Samples. Post-mortem spinal cord tissue samples of thoracic level from two
controls and three ALS patients were used in the study. The cause of death in the two
control subjects was cardiac failure in one case andmyocardial infarction in the other.
At autopsy, the spinal cords were dissected, removed from the dura mater, and cut
into 5-mm sections. The tissue was then immediately frozen on a metal plate
maintained in liquid nitrogen and stored at 272uC. Autopsy was performed with
written approval from the family in accordance with Swedish rules and regulations.
Sample Preparation. Thoracic spinal cord sections (12 mm) were collected using a
cryostate microtome (Thermo Scientific, Waltham, MA) and thaw-mounted on
conductive glass slides (indium tin oxide, ITO, Bruker Daltonics, Bremen, Germany).
The thaw mounted sections were dried under vacuum for 10 min and stored at
280uC until further use. For SIMS experiments, 2 consecutive sections from each
subject were analyzed.
ToF-SIMS Analysis. All ToF SIMS experiments were performed on an IONTOF V
instrument (IONTOF GmbH, Mu¨nster, Germany) equipped with a Bi31 cluster ion
gun as primary ion source. For whole section analysis, data were acquired in high
current bunched mode (HBC)42 with a primary ion current of 0.25 pA at 25 keV and
a maximum ion dose was 1.5 109/cm2. Scans were acquired in positive and negative
ion mode, using the ‘‘stage scan macro raster function’’ with 10 shots per pixel on 0.4
3 0.4 mm areas with 200 measurements per mm resulting in a pixel resolution of
5 mm. This acquisition mode comprises stepwise acquisition of 0.4 3 0.4 mm
patches. Each patch was acquired in electrostatic raster mode where the beam was
moved over the field of view. The whole tissue area was analyzed by stepwise
acquisition of these patches as achieved by stepwise movement of the sample stage.
The mass resolution in high current bunch mode was about M/DM 5 5000.
Data Processing.All data were acquired and processed with the Surface Lab software
(v. 6.3 IONTOF). All spectra were calibrated internally to signals of [C]1, [CH]1,
[CH2]1, [CH3]1, [C5H15PNO4]1 and [C27H45]1 that were used as calibration points
in positive mode and [C]2, [CH]2, [O]2, [C16H31O2]2, [C18H35O2]2 and [C27H45O]2
in negative ion mode. Twomass interval lists were created (one for each ion polarity),
which contained the list of m/z values to be included in multivariate analysis. Mass
interval lists were created by peak search of all individual samples according to the
following search parameters: S/N . 3, width 0.8 Da. The assigned mass peaks were
collected in the same mass interval list and redundant peak assignments removed.
Image data were exported into the *.bif6 format and spectral data were exported
directly from the peak statistics tab into Excel (v. 2010).
Data Analysis. For statistical analysis two approaches were employed comprising
intact image data analysis as well as statistical analysis of spectral data of distinct
regions of interests. For image analysis, *.bif6 files were loaded into PLS-Toolbox (v.
7.02, Eigenvector Research Inc., Wenatchee, WA) running in MatLab (v.12a, The
MathWorks Inc., Natick, MA). Multivariate image analysis was performed by means
of maximum autocorrelation factor analysis (MAF). For comparative statistics on
spectral data, relevant anatomical regions of interest including the grey matter as well
as the ventral horn of the grey matter were outlined followed by reconstruction of the
respective ROI using the corresponding feature in the Surface Lab software
(IONTOF). Two different approaches were employed for comparative, statistical
analysis of ROI spectral data. These included 1) partial least square discriminant
analysis (PLS-DA) as well as 2) ‘‘Statistical Analysis of Microarray data’’ (SAM)26.
Peak area values were log2 normalized followed by SAM based grouped unpaired
statistical analysis (t-statistics) using the corresponding macro in Excel26. PLS-DA
was performed on the spectral data using PLS-Toolbox (Eigenvector Research). Here,
data were mean centered and Poisson scaled. Further analysis of single mass peaks
and comparisons between groups was performed with non-parametric ANOVA
(Kuskal-Wallis) with 95% confidence interval. Identification of mass peaks was done
using tentative assignment by comparing the accurate mass to previously reported
values in the literature27 as well as matching of isotopic distribution.
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